Medicare Enrolled
Dr. Jairo Olivares, MD
Medical Oncology · Garland, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Olivares from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Olivares?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Olivares
Dr. Jairo Olivares is a medical oncology specialist in Garland, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Olivares performed 16,184 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Olivares received a total of $2,663 from 50 pharmaceutical and/or device companies across 134 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Olivares is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 37% volume in TX
$2,663 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗16,184
Medicare services
Top 37% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$2
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,690 | $0 | $5 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,200 | $0 | $2 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
550 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 230 | $0 | $24 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
69 | $101 | $707 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
57 | $49 | $313 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
57 | $23 | $157 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
42 | $12 | $108 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
42 | $93 | $368 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $11 | $96 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
25 | $2 | $19 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
23 | $16 | $100 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
22 | $10 | $75 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
22 | $56 | $211 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
21 | $21 | $161 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $142 | $496 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
21 | $1 | $7 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
19 | $51 | $344 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
14 | $20 | $114 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
11 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
11 | $8 | $36 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
61.4% high complexity
37.8% medium
0.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,663
Total received (2018-2024)
Avg $380/year across 7 years
Bottom 44% in TX for medical oncology
50
Companies
134
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$97
2023
$281
2022
$930
2021
$258
2020
$156
2019
$540
2018
$402
Payments by company (2024)
ABBVIE INC.
$45
PharmaEssentia USA Corporation
$34
PUMA BIOTECHNOLOGY, INC.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$165
PFIZER INC.
$146
Incyte Corporation
$140
Merck Sharp & Dohme LLC
$136
Novartis Pharmaceuticals Corporation
$122
AstraZeneca Pharmaceuticals LP
$117
Rigel Pharmaceuticals, Inc.
$105
E.R. Squibb & Sons, L.L.C.
$103
Pharmacyclics LLC, An AbbVie Company
$95
Seattle Genetics, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$77
EISAI INC.
$71
Gilead Sciences, Inc.
$71
Celgene Corporation
$70
Amgen Inc.
$69
Genentech USA, Inc.
$67
Daiichi Sankyo Inc.
$63
Janssen Biotech, Inc.
$60
Seagen Inc.
$57
Bayer HealthCare Pharmaceuticals Inc.
$55
Puma Biotechnology, Inc.
$50
Myovant Sciences Inc.
$48
ABBVIE INC.
$45
TESARO, Inc.
$42
GENZYME CORPORATION
$40
Global Blood Therapeutics, Inc.
$38
TerSera Therapeutics LLC
$38
Astellas Pharma US Inc
$37
PUMA BIOTECHNOLOGY, INC.
$36
PharmaEssentia USA Corporation
$34
Karyopharm Therapeutics Inc.
$30
Kite Pharma, Inc.
$29
Ipsen Biopharmaceuticals, Inc
$27
AbbVie, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$25
Janssen Pharmaceuticals, Inc
$24
Mirati Therapeutics, Inc.
$23
GlaxoSmithKline, LLC.
$21
Blueprint Medicines Corporation
$20
Lilly USA, LLC
$19
Eisai Inc.
$19
Dova Pharmaceuticals
$18
Teva Pharmaceuticals USA, Inc.
$18
Stemline Therapeutics Inc.
$16
Novocure Inc.
$15
Pharmacyclics LLC, an AbbVie Company
$14
Medtronic USA, Inc.
$12
Acrotech Biopharma LLC
$12
Dendreon Pharmaceuticals LLC
$12
Sirtex Medical Inc
$11
Top 3 companies account for 17.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aranesp · BELEODAQ · BENDEKA · BESREMI · BOSULIF · CALQUENCE · DARZALEX · Doptelet · ELIQUIS · EMEND · ENHERTU · EPKINLY · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · NERLYNX · Nubeqa · OPDIVO · ORGOVYX · OSTEOCOOL RF ABLATION · OXBRYTA · Oncology · Onivyde · Orserdu · PIQRAY · PROVENGE · Perjeta · Phesgo · REBLOZYL · Rezlidhia · SIR-Spheres Microspheres · SPRYCEL · Stivarga · TAGRISSO · TUKYSA · Tavalisse · Trodelvy · VARUBI · VERZENIO · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · XTANDI · YERVOY · ZEJULA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
80
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
PERIMETER BEHAVIORAL HOSPITAL OF DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Olivares is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Olivares experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Olivares performed 9,690 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Olivares receive payments from pharmaceutical companies?
Yes. Dr. Olivares received a total of $2,663 from 50 companies across 134 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Olivares's costs compare to other medical oncologists in Garland?
Dr. Olivares's average Medicare payment per service is $2. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Olivares) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Garland
Browse medical oncologists in Garland ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology